5 Phosphate Imbalances

Phosphate balance and reference values

Phosphate, measured in blood as phosphorus, supports cellular energy, muscle and nerve function, and bone structure. The kidneys regulate phosphate excretion, while the intestines absorb it. A commonly used adult serum range is $2.5\text{–}4.5\,\text{mg/dL}$, but the laboratory's reference range should be followed. Hypophosphatemia is below $2.5\,\text{mg/dL}$, and hyperphosphatemia is above $4.5\,\text{mg/dL}$.

Causes of hypophosphatemia

Low phosphate may result from phosphate moving into cells, inadequate intake or absorption, or increased losses. Refeeding after prolonged undernutrition, recovery from diabetic ketoacidosis, and respiratory alkalosis can shift phosphate into cells. Starvation, malnutrition, alcohol use disorder, and malabsorption can reduce intake or absorption. Increased losses may occur with hyperparathyroidism, vitamin D deficiency, some diuretics, or prolonged use of phosphate-binding antacids or medications. Severe burns and some cases involving parenteral nutrition are also high-risk situations.

Effects of hypophosphatemia

Mild hypophosphatemia may cause no symptoms. Severe or prolonged depletion can cause fatigue, anorexia, muscle weakness, bone pain, or osteomalacia. More serious complications include respiratory muscle weakness or failure, rhabdomyolysis, impaired blood-cell function, confusion, seizures, and coma.

Assessment and care for hypophosphatemia

Assess nutrition history, alcohol use, recent treatment for diabetic ketoacidosis, medications, gastrointestinal losses, and risk of refeeding syndrome. Monitor serum phosphate and related results, especially calcium, potassium, magnesium, and renal function. Assess strength, respiratory effort, mental status, and signs of muscle injury.

Report severe, rapidly falling, or symptomatic phosphate levels promptly. Severe weakness, breathing difficulty, seizures, or altered consciousness require urgent attention.

Give oral or IV phosphate only as prescribed. IV replacement is generally reserved for severe levels, significant symptoms, or inability to take oral replacement. Follow prescribed infusion precautions and monitor phosphate, calcium, potassium, and kidney function closely. Excessive or rapid replacement can cause hypocalcemia and dangerous calcium-phosphate deposits. Potassium-phosphate products also deliver potassium, which matters in renal impairment or when serum potassium is elevated.

For patients at risk of refeeding syndrome, collaborate with the care team on a cautious nutrition plan and close electrolyte monitoring.

Causes of hyperphosphatemia

The most common cause of hyperphosphatemia is reduced kidney excretion, especially in advanced chronic kidney disease. Other causes include hypoparathyroidism; excessive phosphate intake or phosphate-containing products, including some enemas; and phosphate released from damaged cells in rhabdomyolysis, crush injury, tumor lysis syndrome, or diabetic ketoacidosis.

Calcium relationship and effects of hyperphosphatemia

Many people with hyperphosphatemia have no symptoms. Excess phosphate can lower available calcium, so symptoms may reflect hypocalcemia and include tingling around the mouth or in the fingers, muscle cramps, twitching, tetany, or seizures. Severe hypocalcemia may prolong the QTc interval on an ECG; this is an effect of the associated low calcium, not a phosphate-specific ECG pattern. Long-term elevation, particularly in kidney disease, can contribute to calcium-phosphate deposits in soft tissues and blood vessels.

Assessment and care for hyperphosphatemia

Review kidney function, diet, medications, supplements, phosphate-containing laxatives or enemas, and possible tissue injury or tumor lysis. Monitor serum phosphate, calcium, renal function, and relevant electrolytes. Assess for tingling, cramps, tetany, altered mental status, and signs of chronic soft-tissue calcification. Obtain or monitor an ECG when clinically indicated, particularly if hypocalcemia is severe or symptoms suggest dysrhythmia.

Follow the prescribed dietary plan. In chronic kidney disease, this may include limiting high-phosphate foods and phosphate additives; coordinate with a dietitian so restrictions remain nutritionally appropriate. Administer prescribed phosphate binders with meals, as directed, and monitor for effects and adverse reactions. Do not independently start or stop binders or calcium supplements.

Avoid unprescribed phosphate-containing enemas or laxatives, especially for people with kidney disease. Severe acute cases may require prescribed measures such as dialysis.

Applying the clinical patterns

A patient beginning nutrition after prolonged poor intake who develops new weakness may have hypophosphatemia from phosphate shifting into cells during refeeding. Check phosphate and other electrolytes, and promptly report significant symptoms.

For a patient with advanced kidney disease, elevated phosphate, and perioral tingling, consider hyperphosphatemia with possible associated hypocalcemia. Assess symptoms, review calcium and phosphate results, and report findings for further evaluation.